×
模态框(Modal)标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框(Modal)标题
在这里添加一些文本
Close
导航切换
Home
About Journal
Editorial Board
FAQ
Policy & Guide
Guide for Authors
Ethics
Peer Review & Editing
Copyright & Archive
Open Access Policy
Contact Us
中文
A pilot study on the efficacy and safety of anlotinib in the treatment of refractory natural killer/T-cell lymphoma
Gao-yang LI, Ji-feng JIANG, Chuan-xu LIU, Wen-hao ZHANG, Yang ZHU, Yu-jie MA, Rong TAO
JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE) . 2021, (
2
): 196 -201 . DOI: 10.3969/j.issn.1674-8115.2021.02.011